| 441 |
Regulation of Cellular Senescence in Type 2 Diabetes Mellitus: From Mechanisms to Clinical ApplicationsRegulation of Cellular Senescence in Type 2 Diabetes Mellitus: From Mechanisms to Clinical Applications
Kanako Iwasaki, Cristian Abarca, Cristina Aguayo-MazzucatoKanako Iwasaki, Cristian Abarca, Cristina Aguayo-Mazzucato
KMSID: 1516083411 Diabetes Metab J. 2023;47(4):441-453. Published online 2023 March 6 DOI: http://dx.doi.org/10.4093/dmj.2022.0416 |
|
| 454 |
Rediscovering Primary Cilia in Pancreatic IsletsRediscovering Primary Cilia in Pancreatic Islets
Eun Young Lee, Jing W. HughesEun Young Lee, Jing W. Hughes
KMSID: 1516083413 Diabetes Metab J. 2023;47(4):454-469. Published online 2023 April 28 DOI: http://dx.doi.org/10.4093/dmj.2022.0442 |
|
| 470 |
The Role of Echocardiography in Evaluating Cardiovascular Diseases in Patients with Diabetes MellitusThe Role of Echocardiography in Evaluating Cardiovascular Diseases in Patients with Diabetes Mellitus
Sun Hwa Lee, Jae-Hyeong ParkSun Hwa Lee, Jae-Hyeong Park
KMSID: 1516083412 Diabetes Metab J. 2023;47(4):470-483. Published online 2023 July 27 DOI: http://dx.doi.org/10.4093/dmj.2023.0036 |
|
| 484 |
The Beneficial Effect of Glycemic Control against Adverse Outcomes in Patients with Type 2 Diabetes Mellitus and Chronic Kidney DiseaseThe Beneficial Effect of Glycemic Control against Adverse Outcomes in Patients with Type 2 Diabetes Mellitus and Chronic Kidney Disease
Dong-Hwa LeeDong-Hwa Lee
KMSID: 1516083415 Diabetes Metab J. 2023;47(4):484-486. Published online 2023 July 27 DOI: http://dx.doi.org/10.4093/dmj.2023.0165 |
|
| 487 |
Pharmacologic Activation of Angiotensin-Converting Enzyme II Alleviates Diabetic Cardiomyopathy in db/db Mice by Reducing Reactive Oxidative StressPharmacologic Activation of Angiotensin-Converting Enzyme II Alleviates Diabetic Cardiomyopathy in db/db Mice by Reducing Reactive Oxidative Stress
Donghyun Kim, Wooju Jeong, Yumin Kim, Jibeom Lee, Sung Woo Cho, Chang-Myung Oh, Raekil ParkDonghyun Kim, Wooju Jeong, Yumin Kim, Jibeom Lee, Sung Woo Cho, Chang-Myung Oh, Raekil Park
KMSID: 1516083405 Diabetes Metab J. 2023;47(4):487-499. Published online 2023 April 25 DOI: http://dx.doi.org/10.4093/dmj.2022.0125 |
|
| 500 |
Beneficial Effects of a Curcumin Derivative and Transforming Growth Factor-β Receptor I Inhibitor Combination on Nonalcoholic SteatohepatitisBeneficial Effects of a Curcumin Derivative and Transforming Growth Factor-β Receptor I Inhibitor Combination on Nonalcoholic Steatohepatitis
Kyung Bong Ha, Eun Soo Lee, Na Won Park, Su Ho Jo, Soyeon Shim, Dae-Kee Kim, Chan Mug Ahn, Choon Hee ChungKyung Bong Ha, Eun Soo Lee, Na Won Park, Su Ho Jo, Soyeon Shim, Dae-Kee Kim, Chan Mug Ahn, Choon Hee Chung
KMSID: 1516083406 Diabetes Metab J. 2023;47(4):500-513. Published online 2023 April 25 DOI: http://dx.doi.org/10.4093/dmj.2022.0110 |
|
| 514 |
The Risk of Type 2 Diabetes Mellitus according to Changes in Obesity Status in Late Middle-Aged Adults: A Nationwide Cohort Study of KoreaThe Risk of Type 2 Diabetes Mellitus according to Changes in Obesity Status in Late Middle-Aged Adults: A Nationwide Cohort Study of Korea
Joon Ho Moon, Yeonhoon Jang, Tae Jung Oh, Se Young JungJoon Ho Moon, Yeonhoon Jang, Tae Jung Oh, Se Young Jung
KMSID: 1516083408 Diabetes Metab J. 2023;47(4):514-522. Published online 2023 April 25 DOI: http://dx.doi.org/10.4093/dmj.2022.0159 |
|
| 523 |
Two-Year Changes in Diabetic Kidney Disease Phenotype and the Risk of Heart Failure: A Nationwide Population-Based Study in KoreaTwo-Year Changes in Diabetic Kidney Disease Phenotype and the Risk of Heart Failure: A Nationwide Population-Based Study in Korea
Seung Eun Lee, Juhwan Yoo, Han Seok Choi, Kyungdo Han, Kyoung-Ah KimSeung Eun Lee, Juhwan Yoo, Han Seok Choi, Kyungdo Han, Kyoung-Ah Kim
KMSID: 1516083407 Diabetes Metab J. 2023;47(4):523-534. Published online 2023 April 25 DOI: http://dx.doi.org/10.4093/dmj.2022.0096 |
|
| 535 |
Glycemic Control and Adverse Clinical Outcomes in Patients with Chronic Kidney Disease and Type 2 Diabetes Mellitus: Results from KNOW-CKDGlycemic Control and Adverse Clinical Outcomes in Patients with Chronic Kidney Disease and Type 2 Diabetes Mellitus: Results from KNOW-CKD
Ga Young Heo, Hee Byung Koh, Hyung Woo Kim, Jung Tak Park, Tae-Hyun Yoo, Shin-Wook Kang, Jayoun Kim, Soo Wan Kim, Yeong Hoon Kim, Su Ah Sung, Kook-Hwan Oh, Seung Hyeok HanGa Young Heo, Hee Byung Koh, Hyung Woo Kim, Jung Tak Park, Tae-Hyun Yoo, Shin-Wook Kang, Jayoun Kim, Soo Wan Kim, Yeong Hoon Kim, Su Ah Sung, Kook-Hwan Oh, Seung Hyeok Han
KMSID: 1516083409 Diabetes Metab J. 2023;47(4):535-546. Published online 2023 April 25 DOI: http://dx.doi.org/10.4093/dmj.2022.0112 |
|
| 547 |
Ultra-Processed Food Consumption and Obesity in Korean AdultsUltra-Processed Food Consumption and Obesity in Korean Adults
Jee-Seon Shim, Kyoung Hwa Ha, Dae Jung Kim, Hyeon Chang KimJee-Seon Shim, Kyoung Hwa Ha, Dae Jung Kim, Hyeon Chang Kim
KMSID: 1516083404 Diabetes Metab J. 2023;47(4):547-558. Published online 2023 April 26 DOI: http://dx.doi.org/10.4093/dmj.2022.0026 |
|
| 559 |
Change Profiles and Functional Targets of MicroRNAs in Type 2 Diabetes Mellitus Patients with ObesityChange Profiles and Functional Targets of MicroRNAs in Type 2 Diabetes Mellitus Patients with Obesity
Guanhua Lu, Huanhuan Gao, Zhiyong Dong, Shuwen Jiang, Ruixiang Hu, Cunchuan WangGuanhua Lu, Huanhuan Gao, Zhiyong Dong, Shuwen Jiang, Ruixiang Hu, Cunchuan Wang
KMSID: 1516083410 Diabetes Metab J. 2023;47(4):559-570. Published online 2023 April 25 DOI: http://dx.doi.org/10.4093/dmj.2022.0226 |
|
| 571 |
Risk of Diabetic Retinopathy between Sodium-Glucose Cotransporter-2 Inhibitors and Glucagon-Like Peptide-1 Receptor Agonists (Diabetes Metab J 2023;47:394-404)Risk of Diabetic Retinopathy between Sodium-Glucose Cotransporter-2 Inhibitors and Glucagon-Like Peptide-1 Receptor Agonists (Diabetes Metab J 2023;47:394-404)
Jihee Ko, Sun Joon MoonJihee Ko, Sun Joon Moon
KMSID: 1516083414 Diabetes Metab J. 2023;47(4):571-572. Published online 2023 July 27 DOI: http://dx.doi.org/10.4093/dmj.2023.0164 |
|
| 573 |
Risk of Diabetic Retinopathy between Sodium-Glucose Cotransporter-2 Inhibitors and Glucagon-Like Peptide-1 Receptor Agonists (Diabetes Metab J 2023;47:394-404)Risk of Diabetic Retinopathy between Sodium-Glucose Cotransporter-2 Inhibitors and Glucagon-Like Peptide-1 Receptor Agonists (Diabetes Metab J 2023;47:394-404)
Tzu-Yi Lin, Eugene Yu-Chuan Kang, Shih-Chieh Shao, Edward Chia-Cheng Lai, Yih-Shiou HwangTzu-Yi Lin, Eugene Yu-Chuan Kang, Shih-Chieh Shao, Edward Chia-Cheng Lai, Yih-Shiou Hwang
KMSID: 1516083416 Diabetes Metab J. 2023;47(4):573-574. Published online 2023 July 27 DOI: http://dx.doi.org/10.4093/dmj.2023.0188 |
|
